Search Results for keywords:"application notice"

Found 7 results

Search Results: keywords:"application notice"

💰 Only
Oldest Newest
  • 2021-03837 — Bulk Manufacturer of Controlled Substances Application: S&B Pharma, Inc.
    Type:Notice
    Citation:86 FR 11558
    Reading Time:about a minute or two

    S&B Pharma, Inc. has applied to the Drug Enforcement Administration to be registered as a bulk manufacturer of certain controlled substances. The company intends to produce these substances in large quantities for product development and commercial sales. Specifically, S&B Pharma plans to create synthetic versions of Marihuana and Tetrahydrocannabinols. The public and current registered manufacturers have until April 26, 2021, to submit comments or request a hearing on this application.

    Simple Explanation

    S&B Pharma, Inc. wants permission from the government to make lots of special drugs called controlled substances, like fake versions of marijuana. People can tell the government what they think about this plan before April 26, 2021.

  • 2025-00090 — Florida Gas Transmission, LLC; Notice of Application and Establishing Intervention Deadline
    💰
    Type:Notice
    Citation:90 FR 1122
    Reading Time:about 9 minutes

    Florida Gas Transmission Company, LLC has submitted an application to the Federal Energy Regulatory Commission (FERC) for a project in Louisiana. The project aims to upgrade existing equipment and add a new compressor unit, increasing the capacity to transport natural gas to Tampa Electric Company. The public can participate in the review process by commenting, protesting, or intervening before January 30, 2025. More details and instructions on the process for participation are available on the FERC website.

    Simple Explanation

    Florida Gas Transmission wants to make their pipeline from Louisiana bigger, so they can send more gas to a city in Florida. People can let the government know if they like or don’t like this idea by sending comments before the end of January 2025.

  • 2021-02455 — Bulk Manufacturer of Controlled Substances Application: Sterling Pharma USA, LLC
    Type:Notice
    Citation:86 FR 8381
    Reading Time:less than a minute

    The Drug Enforcement Administration (DEA) has announced that Sterling Pharma USA LLC has submitted an application to become a bulk manufacturer of controlled substances. Specifically, they plan to produce Tetrahydrocannabinols from hemp extract. People who are currently registered as bulk manufacturers of these substances, or who are applying to be, have the opportunity to file comments or objections regarding this application by April 6, 2021. They can also request a hearing before the same deadline.

    Simple Explanation

    Sterling Pharma USA wants to make some special medicines and has asked for permission from the government. Other companies who also make these medicines can say what they think about this by April 6, 2021.

  • 2025-04044 — Bulk Manufacturer of Controlled Substances Application: Sigma Aldrich Research Biochemicals Inc.
    Type:Notice
    Citation:90 FR 11998
    Reading Time:about a minute or two

    Sigma Aldrich Research Biochemicals Inc. has applied to the Drug Enforcement Administration to become a registered bulk manufacturer of certain controlled substances. The company intends to produce these substances for use as reference standards only, and no other uses are approved under this registration. The public can submit comments or objections electronically regarding this application until May 12, 2025, through the Federal eRulemaking Portal. Additionally, requests for a hearing on the application must also be made by this date.

    Simple Explanation

    Sigma Aldrich Research Biochemicals Inc. wants permission to make certain special chemicals that are controlled by the law, and people can say what they think about it online until May 12, 2025.

  • 2021-00648 — Bulk Manufacturer of Controlled Substances Application: Siemens Healthcare Diagnostics Inc.
    Type:Notice
    Citation:86 FR 3197
    Reading Time:less than a minute

    Siemens Healthcare Diagnostics Inc. has submitted an application to the Drug Enforcement Administration to become a bulk manufacturer of certain controlled substances. The company intends to use these substances to produce products that are exempt from DEA regulations. Individuals or existing registered manufacturers can express their support or objections in writing by March 15, 2021, or request a hearing regarding this application by the same date.

    Simple Explanation

    Siemens Healthcare Diagnostics Inc. wants to make certain special medicines, and they have asked for permission from a group that checks if it's okay. People who have thoughts or worries about this can write to the group or ask to talk with them by March 15, 2021.

  • 2021-00757 — Applications for New Awards; Fulbright-Hays Group Projects Abroad Program
    💰
    Type:Notice
    Citation:86 FR 3142
    Reading Time:about 21 minutes

    The Department of Education has announced the opening for applications for the Fulbright-Hays Group Projects Abroad (GPA) Program for fiscal year 2021. This program aims to promote the study of modern foreign languages and area studies by offering opportunities for faculty, teachers, and students to conduct projects overseas. The available funding is approximately $3.5 million, with awards ranging from $50,000 to $250,000 for short-term and long-term projects. Eligible applicants include higher education institutions, state educational agencies, nonprofit educational organizations, and consortia of these entities.

    Simple Explanation

    The Department of Education is letting people know they can apply for money to go study and learn languages in other countries. It's like a special trip for learning, but they must be careful because there might not be enough money to go around for everyone who wants to apply.

  • 2021-02973 — Bulk Manufacturer of Controlled Substances Application: PCI Synthesis
    Type:Notice
    Citation:86 FR 9539
    Reading Time:about a minute or two

    PCI Synthesis has applied to the Drug Enforcement Administration (DEA) to become a bulk manufacturer of controlled substances. They plan to use these substances for developing manufacturing processes and conducting tests. The application has been filed under notice by the DEA, and comments or objections to this application can be submitted by April 19, 2021. Additionally, PCI Synthesis has patents for the synthesis process of amphetamines.

    Simple Explanation

    PCI Synthesis wants permission to make certain special chemicals and is asking the government for approval, and people have until April 19, 2021, to say if they agree or not. They also have special recipes for how to make these chemicals.